Weijia Fang

21PUBLICATIONS
113CO-AUTHORS
Molecular targetsMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 30, 2026
Phase I Trial of GPC3-Targeted TCR Fusion Construct, CT0180, in patients with Advanced Hepatocellular Carcinoma.

|Mar 10, 2026
AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling.

Chuan Liu, Chuan Hu, Jinlin Cheng

|Feb 27, 2026
Hypoxia-responsive CEA-targeted CAR T cells in CEA-positive solid tumors through intraperitoneal or intravenous infusion: a phase 1 trial.

Yang Gao, Jie Li, Hangyu Zhang

|Apr 15, 2025
Spatial multi-omics profiling of breast cancer oligo-recurrent lung metastasis.

Yang Gao, Bin Li, Yuzhi Jin

|Jul 27, 2024
The long-term effectiveness and mechanism of oncolytic virotherapy combined with anti-PD-L1 antibody in colorectal cancer patient.

Hangyu Zhang, Yiqing Ren, Feiyu Wang

|Mar 06, 2024
Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells.

Jiaqi Shi, Wei Wu, Dong Chen

Pageof 4

Frequent Collaborators

7 joint publications

Peng Zhao

6 joint publications

Xuanwen Bao

4 joint publications

Xiaomeng Dai

3 joint publications

Bin Li